about
Association of the human SUMO-1 protease SENP2 with the nuclear poreNMR structure of the N-terminal domain of SUMO ligase PIAS1 and its interaction with tumor suppressor p53 and A/T-rich DNA oligomersMuscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1Active site remodelling accompanies thioester bond formation in the SUMO E1Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1)The SUMO E3 ligase activity of Pc2 is coordinated through a SUMO interaction motifEnzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formationModification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcriptionSUMOylation enhances DNA methyltransferase 1 activityStructure of Importin13-Ubc9 complex: nuclear import and release of a key regulator of sumoylationRegulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.SUMO-1 modification of human transcription factor (TF) IID complex subunits: inhibition of TFIID promoter-binding activity through SUMO-1 modification of hsTAF5Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activityModification with SUMO. A role in transcriptional regulationModification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnoverTranscription factor Sp3 is silenced through SUMO modification by PIAS1The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylaseNucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2Role for SUMO modification in facilitating transcriptional repression by BKLF.Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functionsProtein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult lifeSENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodiesSUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expressionRSUME enhances glucocorticoid receptor SUMOylation and transcriptional activityhZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication fociHistone sumoylation is associated with transcriptional repressionUbiquitin-proteasome system as a modulator of cell fateSUMO-1 targets RanGAP1 to kinetochores and mitotic spindlesSUMO-2/3 regulates topoisomerase II in mitosisSumoylation is involved in beta-catenin-dependent activation of Tcf-4Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1At the crossroads of SUMO and NF-kappaBDNA repair factor XPC is modified by SUMO-1 and ubiquitin following UV irradiationThe Ubiquitin System and Jasmonate SignalingAdvances in the development of SUMO specific protease (SENP) inhibitorsPost-translational modifications of the progesterone receptors
P2860
Q24292472-A8E72B8E-11B8-4720-8008-84F37CC4FA55Q24292722-C35D0CC4-0871-49CD-B5F3-A56C162B24BAQ24293032-EEDA94D1-A236-4F2E-B89A-EA40F8E09BAEQ24299970-1CEDF3E0-6626-4B0B-9809-2E52DDC6247DQ24300283-36385DE8-C9F7-4EB9-94C5-06C2335B3862Q24300562-44467162-2533-4DA5-9211-045983E0A748Q24305181-76893AA2-173F-4370-A326-9834CE74B643Q24305202-7B99B22C-C3EF-4CA6-A6B3-5B0F54395445Q24306717-1CDD20E5-524A-4240-AE0C-A3E4FDCAE0D4Q24311725-ABD1A5A9-88C9-4225-8456-7312D1BE48F6Q24313610-6EBB9CA7-8BF4-4F9E-BDBD-D88E97B34A03Q24324035-4BF2125D-19C3-47BA-B2BB-60BC1AE0B12AQ24337572-650FBD1C-7C3C-4357-A47E-D904E13EBCC1Q24338548-8959D63E-6DF5-435A-83EE-BAF1BC6C98F2Q24529191-DE4A3FF1-D549-42AE-BBA7-1CF03153C9DDQ24531180-276AB6F6-F712-4EB6-8F30-6314F34F2983Q24534589-13FBECB2-CFE7-40BD-8971-6479BB9031FCQ24534803-73F62091-64C4-498A-B420-BBC8CC1B6247Q24534887-A91A77E7-E49E-4BF8-9360-E7811348D963Q24534918-70A65930-BB87-48DF-8E76-8EC8BB906DF5Q24548973-CC173DE3-2487-4E35-87B0-276F74A6A224Q24556900-66EAA511-D02A-451D-B588-8075BA5B615EQ24561624-9E181561-F541-4B3A-BEF8-A4163AC60DCDQ24561977-A607C303-F0BE-41AF-8145-E28B29EDA26CQ24563640-23F4489D-886E-40FC-A3D2-30A592286FA1Q24599898-24133C3D-2A15-4EB2-96A0-F8E030400E2AQ24604578-C28DBA45-1A5D-422D-9912-ED9223308DBEQ24629429-F1497AA4-20B1-4A9E-A460-0535902B036AQ24644349-7F98740D-0026-4D3A-8ACF-27427B7D2823Q24656259-6B59DE50-BBB4-4457-B92B-EC0D8AD8DA43Q24656277-C6465F6A-1233-4EC1-B9D9-DECE8F109B17Q24671070-28301FC1-D1DB-4AE1-B2DA-131110492BB2Q24672260-C51EF3FF-7573-475F-A9C1-6CE403D8D83AQ24675969-D33A0382-390B-4055-9B47-C2C95CFD8AA3Q24685095-A2CE4B5A-6C67-4D1E-880B-DF55DEFEA874Q24798022-FF4B1184-B696-4CC7-BCF4-411AF88E05CBQ24813820-13C743FC-D0CF-4B75-9553-D2C0F2B4C8FEQ26748467-CF23705A-7F74-493F-9FD7-2A43849C1309Q26864235-11140E2E-C1E9-4F3A-A806-751F7462678BQ27010251-0D2F11B8-5623-4737-8ADA-AFD26C8EEA09
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականին հրատարակուած գիտական յօդուած
@hyw
2000 թվականին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
SUMO--nonclassical ubiquitin
@ast
SUMO--nonclassical ubiquitin
@en
type
label
SUMO--nonclassical ubiquitin
@ast
SUMO--nonclassical ubiquitin
@en
prefLabel
SUMO--nonclassical ubiquitin
@ast
SUMO--nonclassical ubiquitin
@en
P3181
P1476
SUMO--nonclassical ubiquitin
@en
P2093
Melchior F
P304
P3181
P356
10.1146/ANNUREV.CELLBIO.16.1.591
P407
P577
2000-01-01T00:00:00Z